Key clinical point: Age older than 65 years was significantly associated with increased odds of death for hospitalized inflammatory bowel disease patients.

Major finding: In a multivariate analysis, age older than 65 years was independently associated with increase in risks of mortality for patients with Crohn’s disease (odds ratio, 3.47) and ulcerative colitis (OR, 2.75).

Study details: The data come from a retrospective study of about 162,800 hospital admissions for Crohn’s disease and 96,450 for ulcerative colitis between 2016 and 2017 using information from the National Inpatient Sample.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose. Dr. Cohen disclosed relationships with multiple companies including AbbVie, Takeda, Bristol-Myers Squibb/Celgene, Eli Lilly, Gilead Sciences, Janssen, Pfizer, and UCB Pharma.